Orchid Pharma Gets USFDA Approval for Aripiprazole OD Tab | CORPORATE ETHOS

Orchid Pharma Gets USFDA Approval for Aripiprazole OD Tab

By: | December 13, 2017
pharma sector

Dec 13: Chennai-based drug maker Orchid Pharma Ltd on Wednesday said that it has received ANDA approval from the USFDA for its Aripiprazole Orally-Disintegrating Tablets USP, 10 mg and 15 mg.

According to the company, Aripiprazole Orally-Disintegrating Tablets are atypical antipsychotic, indicated in the treatment symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression).

Incorporated in 1992, Orchid Pharma specializes in the development and manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms, new drug discovery (NDD), novel drug delivery systems (NDDS) and contract research and manufacturing services (CRAMS).